Phenomix

company

About

Phenomix is a drug discovery and development company building a portfolio of novel therapeutics for the treatment of major human diseases.

  • 1 - 10

Details

Last Funding Type
Series C
Last Funding Money Raised
$55M
Industries
Biotechnology,Health Care,Pharmaceutical
Founded date
Jan 1, 2001
Number Of Employee
1 - 10
Operating Status
Active

As of October 2010, Phenomix closed down as it was unable to find a partner to pay for is clinical trial bills after Forest Laboratories walked away.

Phenomix is a drug discovery and development company building a portfolio of novel therapeutics for the treatment of major human diseases. Phenomix' lead clinical candidate, PHX1149, is a DPP4 inhibitor in phase 2 testing as a once daily oral treatment for type 2 diabetes. Phenomix' second program is directed at the treatment of hepatitis C through inhibition of the NS3/4A viral protease. Phenomix is based in San Diego, California.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$67M
Phenomix has raised a total of $67M in funding over 2 rounds. Their latest funding was raised on Mar 8, 2007 from a Series C round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Mar 8, 2007 Series C $55M 1 Phase4 Ventures Detail
Mar 11, 2002 Series A $12M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
2
Phenomix is funded by 2 investors. Phase4 Ventures and Versant Ventures are the most recent investors.
Investor Name Lead Investor Funding Round
Phase4 Ventures Yes Series C
Versant Ventures Series A